Jeffery Kutok

Jeffery Kutok, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Epizyme, Inc. and Infinity Pharmaceuticals, Inc. Between 2 January 2018 and 12 August 2022, the trades on record add up to 15 filings.

The open-market record consists of 6 sales worth €70k, with no purchase. The rest of the record consists of 6 share grants and 1 option exercise. So far in 2022, the count stands at no purchases and 2 sales.

The newest entry dates from 16 August 2022: a transaction, in Epizyme, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.